Das Spitalzentrum Biel ist das öffentliche Spital der Region Biel–Seeland–Berner Jura in der Schweiz. Es befindet sich in Biel im über der Stadt liegenden Quartier Beaumont.

During the past decade, Spitalzentrum Biel conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalzentrum Biel" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 22 trials, followed by "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "Eisai Limited" with 1 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalzentrum Biel" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Borstkanker Onderzoek Groep" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "Cantonal Hospital of St. Gallen" with 1 trials as a collaborator and "Central European Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Spitalzentrum Biel" are "Breast Cancer" (6 trials), "Prostate Cancer" (4 trials), "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials) and "Metastatic Colorectal Cancer" (2 trials). Many other conditions were trialed in "Spitalzentrum Biel" in a lesser frequency.

Most popular intervention types in "Spitalzentrum Biel" are "Drug" (21 trials), "Biological" (5 trials), "Radiation" (4 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "capecitabine" (3 trials), "cetuximab" (2 trials), "docetaxel" (2 trials), "3-dimensional conformal radiation therapy" (1 trials) and "Bevacizumab, Cyclophosphamide, Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spitalzentrum Biel" are 15 trials for "All" genders, 7 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Spitalzentrum Biel". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Spitalzentrum Biel, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalzentrum Biel, 1 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".